|
“Congratulations on a great meeting. Excellent learning opportunities and fun networking” Dr Herbert Fritsche, Professor, Laboratory Medicine & Chief, Clinical Chemistry Section, MD Anderson Cancer Centre – Delegate at SMi’s 2007 Biomarker Event SMi’s Biomarkers Summit, the 5th in the biomarkers series offers a unique opportunity to hear about the latest developments from industry leaders. Examine the latest developments in the biomarker research, and listen to case studies from the leading companies in the field. Discussions will include issues on the latest developments in biomarker research from discovery to validation to clinical issues; - Biomarkers in early clinical drug development
- Biomarker validation
- Protein biomarker discovery
- Biomarkers as a diagnosis tool
Bringing together knowledge and expertise, it’s designed to create the perfect setting for the exchange of ideas and networking opportunities. Confirmed speakers include: - Mark Fidock, Associate Research Fellow, Head of Biochemical & Molecular Pharmacology, Biomarkers & Translational Biology, Pfizer
- Ashok Dongre, SRI, Clinical Discovery, Bristol Myers Squibb
- Dr Michael Tacke, Director, Proteomics, Roche Diagnostics Gmbh
- Lisa Kyriacou Faulks, Global Biosamples Specialist, Biomarkers & Experimental Medicine, Roche Products
- Dr Barroso Begona, Associate Director, Bioanalysis, Astellas Pharma International B V
- Dr Hans Winkler, Senior Director Translational Research, Oncology, Johnson & Johnson
- Dr Mark Manfredi, Associate Director, Oncology, Millennium Pharmaceuticals
- Professor William Gallagher, Associate Professor of Cancer Biology, University College Dublin and CEO/CSO OncoMark Ltd
- Georg Wensing, Head, Pharmacodynamics, Clinical Pharmacology, Bayer
Professor Caroline Dive, Head of Clinical & Experimental Pharmacology, Paterson Institue for Cancer Research, University of Manchester Dr Johannes Lampe, Managing Partner, Lampe Konieczny & Company Professor Karol Sikora, Professor, Cancer Medicine, Imperial College, Hammersmith Hospital, London and Scientific Director, Medical Solutions
Chaired by: Professor William Gallagher, Associate Professor of Cancer Biology, University College Dublin and CEO/CSO OncoMark Ltd
Who Should Attend this Conference? Vice Presidents,Directors, Heads & Scientists working in the following fields: - Biomarkers
- Screening
- Genomics
- Toxicity
- Imaging
- Bioinformatics
- Proteomics
|
Events Home Page
